Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on INT 1. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN108659031A offers mild conditions for eribulin intermediate. Enhances supply chain reliability and reduces manufacturing costs for pharma partners.
This patent details a novel biocatalytic route for sitagliptin intermediates offering high purity and yield. It enables significant cost reduction and supply chain reliability for pharmaceutical manufacturing partners.
Novel synthesis route for Topramezone intermediate. High purity, mild conditions, cost-effective manufacturing for global supply chains.
Novel preparation method for Gadoxetate disodium intermediate offering high purity and industrial scalability for pharmaceutical supply chains globally.
Patent CN114591216A reveals a novel acid-catalyzed route for omacycline intermediates, offering superior purity profiles and streamlined manufacturing for global supply chains.
Novel patent CN113788766B offers safer synthesis route. Reduces toxic reagents. High purity supply chain solution for global pharmaceutical manufacturers.
Patent CN1213991C reveals a copper-catalyzed route for high-purity sertraline intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Novel synthetic method for Polmacoxib intermediate avoiding cyanide. High purity, scalable process for pharmaceutical supply chains.
Patent CN106905226A reveals a cost-effective, three-step synthesis for Alectinib intermediates. Discover scalable, high-yield manufacturing solutions for global supply chains.
Novel patent CN106928125A details efficient Alectinib intermediate synthesis. Reduces steps, eliminates chromatography, ensures high purity for reliable pharmaceutical intermediates supplier chains.
Novel patent CN106892860B offers cost-effective Alectinib intermediate synthesis. Enhances supply chain reliability and reduces manufacturing complexity for global pharmaceutical partners.
Novel asymmetric catalysis method improves yield and purity for Carfilzomib intermediate manufacturing ensuring supply chain stability and cost efficiency.
Novel patent CN108658931A offers high-yield route for Raltitrexed intermediate. Reduces toxic waste and ensures supply chain stability for pharmaceutical manufacturing.
Patent CN118056823A reveals a scalable route for high-purity Platinib intermediates. This process eliminates chromatography, ensuring cost reduction and supply reliability for pharmaceutical manufacturers.
Patent CN109438351B details a high-yield, safe route for pentazocine intermediates, eliminating explosive reagents and high-pressure conditions for cost-effective manufacturing.
Novel rhodium-catalyzed route for indaziflam intermediate offers high ee value and industrial scalability for agrochemical supply chains.
Patent CN113214263B reveals a high-yield synthetic route for Remdesivir key intermediates, offering significant cost reduction and scalable manufacturing for global pharmaceutical supply chains.
Novel chiral induction method for Rotigotine intermediate. Reduces cost and improves scalability for pharmaceutical manufacturing supply chains globally.
Patent CN103333129A reveals a KI-catalyzed methylation route for agrochemical intermediates, delivering >90% yield and eliminating high-pressure gas hazards.
Advanced preparation method for Vonoprazan intermediates via Cobalt catalysis. Offers high yield, cost reduction, and reliable supply chain for pharmaceutical manufacturing.